scispace - formally typeset
J

Jason Park

Researcher at Yale University

Publications -  18
Citations -  5293

Jason Park is an academic researcher from Yale University. The author has contributed to research in topics: Immunotherapy & Transforming growth factor beta. The author has an hindex of 12, co-authored 18 publications receiving 3280 citations.

Papers
More filters
Journal ArticleDOI

Label-free biomarker detection from whole blood.

TL;DR: This work shows specific and quantitative detection of two model cancer antigens from a 10 uL sample of whole blood in less than 20 minutes and reduces its minimum required sensitivity by effectively pre-concentrating the biomarkers.
Journal ArticleDOI

Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy

TL;DR: N nanoscale liposomal polymeric gels (nanolipogels; nLGs) of drug-complexed cyclodextrins and cytokine-encapsulating biodegradable polymers that can deliver small hydrophobic molecular inhibitors and water-soluble protein cytokines in a sustained fashion to the tumour microenvironment significantly delayed tumour growth and increased survival of tumour-bearing mice.
Journal ArticleDOI

PEGylated PLGA nanoparticles for the improved delivery of doxorubicin

TL;DR: It is hypothesized that the efficacy of doxorubicin (DOX) can be maximized and dose-limiting cardiotoxicity minimized by controlled release from PEGylated nanoparticles.
Journal ArticleDOI

Modulation of CD4+ T Lymphocyte Lineage Outcomes with Targeted, Nanoparticle-Mediated Cytokine Delivery

TL;DR: This targeted nanoparticle approach is able to harness endogenous immune-regulatory pathways, providing a powerful new method to modulating T cell developmental plasticity in immune-mediated disease indications.